Under the agreement, Medtronic plans to make the minimally invasive system available this year, adding a new modality to a pain treatment portfolio that already spans spinal cord stimulation, vertebral augmentation, nerve ablation, bone tumor ablation and targeted drug delivery. Picture Courtesy: Shutterstock
